Valuation: Norda ASA

Market Cap 513M 54.49M 47.46M 44.92M 40.81M 76.24M 5.22B 76.62M 535M 207M 2.65B 205M 200M 8.49B P/E 2023 *
-
P/E 2024 3.26x
Enterprise Value 264M 28.07M 24.45M 23.14M 21.02M 39.27M 2.69B 39.47M 276M 107M 1.37B 105M 103M 4.37B EV / Sales 2023
-1.24x
EV / Sales 2024 0.4x
Free-Float
6.26%
Yield 2023 *
-
Yield 2024 32.5%
Manager TitleAgeSince
Chief Executive Officer - 07/04/2013
Director TitleAgeSince
Chairman 54 30/01/2014
Director/Board Member 68 19/06/2013
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+3.37%-6.12% - - 47.19M
+1.23%+1.87%-0.15%+9.57% 45.91B
+0.23%+4.72%+44.32%+27.27% 44.25B
+0.52%-3.15%+349.53%+520.09% 41.99B
+1.55%+3.41%+6.40%+76.45% 39.58B
+1.75%-0.28%+12.42%+41.11% 31.08B
-0.20%+5.49%+23.57%+119.72% 17.21B
-3.49%-8.49% - - 16.27B
+2.92%+8.40%+22.46%+38.87% 14.96B
-2.45%+2.41%-3.16%-35.16% 13.42B
Average +0.54%+0.77%+56.93%+99.74% 29.41B
Weighted average by Cap. +0.59%+0.33%+72.35%+120.61%

Financials

2023 2024
Net sales 86.92M 9.23M 8.04M 7.61M 6.91M 12.91M 884M 12.98M 90.62M 35.04M 449M 34.67M 33.9M 1.44B 372M 39.48M 34.39M 32.55M 29.57M 55.24M 3.78B 55.52M 388M 150M 1.92B 148M 145M 6.15B
Net income 31.17M 3.31M 2.88M 2.73M 2.48M 4.63M 317M 4.65M 32.5M 12.57M 161M 12.43M 12.16M 516M 126M 13.37M 11.65M 11.02M 10.02M 18.71M 1.28B 18.8M 131M 50.77M 651M 50.24M 49.12M 2.08B
Net Debt -311M -33.05M -28.78M -27.24M -24.75M -46.24M -3.16B -46.47M -324M -125M -1.61B -124M -121M -5.15B -249M -26.42M -23.01M -21.78M -19.79M -36.97M -2.53B -37.15M -259M -100M -1.29B -99.25M -97.04M -4.12B
Logo Norda ASA
Norda ASA, formerly NorDiag ASA, is a Norway-based company active within the biotechnology sector. It develops, manufactures and markets automated solutions (instruments and tests) for sample preparation of bacterial and human DNA from difficult biological samples for use in the fields of infectious diseases, transplantation testing (HLA Typing) and others. The Company’s products include NorDiag Arrow (CE, IVD), which is a compact, automated solution for nucleic acid extractions, as well as NorDiag Bullet, 8 tip config, which is a fully automated sample preparation instrument for molecular diagnostics and can isolate from samples such as urine, swab, faces, sputum and blood. Its distribution products include Molzym GmbH and Co KG, as well as Hain Lifescience GmbH. Its customers are clinical laboratories, hospitals, research institutes, medical diagnostics and healthcare providers. It is operational through offices and laboratories in Norway, Sweden, Austria and the United States.
Employees
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!